Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Amoy Diagnostics Co., Ltd. (300685.SZ)

Shenzhen - Shenzhen Delayed Price. Currency in CNY
Add to watchlist
23.18-0.40 (-1.70%)
At close: 03:04PM CST
Advertisement

Amoy Diagnostics Co., Ltd.

39 Dingshan Road
Haicang District
Xiamen 361027
China
86 59 2680 6835
https://www.amoydx.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full Time Employees1,096

Key Executives

NameTitlePayExercisedYear Born
Mr. Jiemin LuoGM & DirectorN/AN/A1983
Ms. Ying ChenCFO & Sec. to the Board of DirectorsN/AN/A1970
Mr. Ruan LiDeputy GM & CTON/AN/A1978
Ms. Fei LuoDeputy GM & DirectorN/AN/A1978
Mr. Guanshan ZhuDeputy GM & DirectorN/AN/A1964
Mr. Huibin ZhengDeputy Gen. Mang.N/AN/A1962
Mr. Frank Ron ZhengDeputy GM & DirectorN/AN/A1990
Mr. Shouqian YangSecurities RepresentativeN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Amoy Diagnostics Co., Ltd., a diagnostic company, focuses on molecular diagnostics for oncology precision medicine in China and internationally. The company offers NGS, real-time PCR, FISH, and extraction assays. Amoy Diagnostics Co., Ltd. was founded in 2008 and is based in Xiamen, China.

Corporate Governance

Amoy Diagnostics Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement